Literature DB >> 22847877

Juvenile recurrent respiratory papilloma: variable intersurgical intervals.

Julina Ongkasuwan1, Ellen M Friedman.   

Abstract

OBJECTIVES/HYPOTHESIS: To analyze the patterns of surgical frequency in pediatric patients undergoing surgery with CO(2) laser ablation for juvenile onset recurrent respiratory papillomatosis (JORRP). The hypothesis is that over time there is a high variability in surgical frequency independent of the use of an adjuvant therapy. STUDY
DESIGN: Retrospective case review.
METHODS: All pediatric patients treated surgically with the CO(2) laser for JORRP by two senior surgeons at a tertiary pediatric hospital over an 11-year period were evaluated. Regression analysis was performed. An online survey was conducted of the American Academy of Pediatric Otolaryngology membership on their practice patterns regarding JORRP.
RESULTS: Twenty-nine patients were identified, and of those, 20 were included in regression analysis. Several distinct patterns were noted. Only five of the 20 patients (25%) had a constant rate of procedures throughout the observation period. Three (15%) of the patients had continual decrease and one (5%) of the patients had a continual increase in the surgical rate throughout the study period. Eleven (55%) had a fluctuation in the pattern of their recurrences. When queried on how they approach when to repeat intervention for JORRP patients, more than 16 responses were given, and the most common determinants included standard set interval, previous operative findings, and previous interval.
CONCLUSIONS: The natural fluctuation in intersurgical intervals without the use of any adjuvant therapy confounds the use of intersurgical interval as an outcome measure for the success of adjuvant therapy. Accelerations and decelerations were noted but cannot be explained.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22847877     DOI: 10.1002/lary.23534

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis.

Authors:  Matthew M Moldan; Bruce C Bostrom; Robert J Tibesar; Timothy A Lander; James D Sidman
Journal:  F1000Res       Date:  2013-10-03

2.  Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.

Authors:  Farrel J Buchinsky; William L Valentino; Nicole Ruszkay; Evan Powell; Craig S Derkay; Riaz Y Seedat; Virgilijus Uloza; Frederik G Dikkers; David E Tunkel; Sukgi S Choi; Anthony J Mortelliti; Paolo Campisi; Juan C Ospina; Adam J Donne; Robert T Sataloff; Stephen F Conley; John E McClay; Ellen M Friedman; Lisa Elden; Dale A Tylor; Clark A Rosen; Libby J Smith; Graeme J Copley; David E Karas; John M Schweinfurth; Charles M Myer; Brian J Wiatrak; Joseph E Dohar; Steven E Sobol; Robert W Bastian; Richard J H Smith; Marshall E Smith; Abebe M Wassie; James C Post; Garth D Ehrlich
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

Review 3.  Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.

Authors:  R Y Seedat
Journal:  Pediatric Health Med Ther       Date:  2020-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.